0 Commentaires
0 Parts
471 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Reels
-
Blogs
-
Offres
-
Emplois
-
Connectez-vous pour aimer, partager et commenter!
-
Growing Focus on Rare Disease Treatments Supporting Orphan Drugs Market ExpansionThe global orphan drugs market was valued at USD 195.0 Bn in 2023 and is projected to experience steady growth over the coming years. The industry is expected to expand at a CAGR of 6.9% from 2024 to 2034, reaching USD 424.0 Bn by the end of 2034. The growth of the market is driven by increasing research and development activities for rare diseases, supportive government policies, and rising...0 Commentaires 0 Parts 190 Vue 0 Aperçu
-
Rare Disease Therapy: Pipeline Drugs and Forecast for the Epidermal Nevus Syndrome Treatment Market.The Epidermal Nevus Syndrome Treatment Market is a niche segment within the rare diseases and dermatology therapeutics space. Epidermal Nevus Syndrome (ENS) refers to a group of complex disorders characterized by the presence of congenital skin lesions (epidermal nevi) associated with extra-cutaneous abnormalities, often affecting the nervous, ocular, and skeletal systems. Treatment...0 Commentaires 0 Parts 680 Vue 0 Aperçu
-
Rare Disease Therapy: Pipeline Drugs and Forecast for the Epidermal Nevus Syndrome Treatment Market.The Epidermal Nevus Syndrome Treatment Market is a niche segment within the rare diseases and dermatology therapeutics space. Epidermal Nevus Syndrome (ENS) refers to a group of complex disorders characterized by the presence of congenital skin lesions (epidermal nevi) associated with extra-cutaneous abnormalities, often affecting the nervous, ocular, and skeletal systems. Treatment...0 Commentaires 0 Parts 697 Vue 0 Aperçu
-
What Is Driving Growth in the MNGIE Treatment Market?Regional Overview of Executive Summary Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE) Market by Size and Share CAGR Value The global Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE) market size was valued at USD 2.50 billion in 2024 and is expected to reach USD 3.16 billion by 2032, at a CAGR of 3.00% during the forecast period It is the necessity of this...0 Commentaires 0 Parts 209 Vue 0 Aperçu